Previous clinical studies demonstrated that IFN-ɣ treatment could restore monocytic HLA-DR expression, the secretion of TNF-α upon ex vivo LPS stimulation, and reduce infection-related mortality31,32. The gene discussed is TNF; the disease is infection.